$BGDE Cashflow Statement | Understand Stock

$BGDE

$4.02 +$0.37 (10.14%) Close

$BGDE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
LO2A write offs
Non-cash lease expense
Unrealized loss on marketable securities
Unrealized gain on derivative asset
Non-cash proceeds from the sale of intellectual property
Impairment on equity accounted associate investment
Depreciation and amortization
Amortization of operating lease right-of-use asset
Foreign exchange loss
Sale of intellectual property
Foreign exchange loss (gain)
Stock based compensation
Unrealized (gain) loss on derivative asset
Fair value loss on investments
Share of loss of equity accounted investments
Proceeds from sales of property and equipment
Payment of fixed asset deposits
Share of loss of from equity accounted method investments
(Gain) loss on sale of marketable securities
Loss on write off on property and equipment
Loss on sale of property, plant and equipment
Non- cash interest expense
Non-controlling interest
Interest on convertible notes satisfied by issue of notes
Interest accrued
Gain on disposal of fixed assets
Acquisition of Wize Pharma Inc
Buyout of non-controlling interest
Gain on deconsolidation
Non-cash consideration received in the form of shares
Bad debt expense
Non-cash interest expense
Loss on lease termination
Profit on sale of site
Loss on deconsolidation
Impairment on equity accounted method investment
Changes in operating assets and liabilities:
Trade and other receivables
Other current assets
Operating lease liabilities
Other current assets
Trade and other payables

Net cash (used in) provided by operating activities
CASH FLOWS FROM INVESTING ACTIVITIES
Payment for the purchase of property and equipment
Proceeds from sale of investments
Purchase of investment shares
Capital expenditures
Proceeds from sale of site
Deposits received in relation to sale of Georgia site
Proceeds from sales of property, plant and equipment
Payment of fixed asset deposits
Proceeds from sale of marketable securities
Payment of property and equipment deposits
Net cash used in investing activities

CASH FLOWS FROM FINANCING ACTIVITES
Payments of stock issuance costs
Proceeds from borrowings
Repayment of lease liabilities
Repayments of borrowings
Proceeds from convertible notes
Proceeds from loans
Proceeds from common share issuances
Payment of finance lease liabilities
Payments of loans
Net cash provided by (used in) financing activities
Effect of exchange rate changes on cash and cash equivalents
Net increase in cash and cash equivalents

Net increase in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosure of cash flow information
Cash paid for interest
Cash paid for income taxes
Sale of site in exchange for shares
Sale of property and equipment in exchange for shares
Cash (received) paid for income taxes – Federal
Cash paid for income taxes – State
Non-cash transactions
Accrued interest on convertible notes settled in common stock
Recognition of right of use operating asset and lease liability

Comments